Treprostinil Sodium

CHEMBL561157 Phase 4 Zugelassen Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
412.5 g/mol
LogP
Phase
4

Treprostinil sodium is the sodium salt form of treprostinil, a synthetic prostacyclin analog used for pulmonary arterial hypertension via continuous subcutaneous or intravenous infusion and inhaled delivery. See treprostinil for complete pharmacological details. This salt formulation is used in sterile injectable preparations for continuous infusion therapy in COPD-associated pulmonary hypertension and PAH.

Molekularmasse

412,5000 g/mol

TPSA

89,80 Ų

Therapeutische Bereiche

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D-Struktur

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCCC[C@H](O)CC[C@@H]1[C@H]2Cc3cccc(OCC(=O)[O-])c3C[C@H]2C[C@H]1O.[Na+]

InChI

InChI=1S/C23H34O5.Na/c1-2-3-4-7-17(24)9-10-18-19-11-15-6-5-8-22(28-14-23(26)27)20(15)12-16(19)13-21(18)25;/h5-6,8,16-19,21,24-25H,2-4,7,9-14H2,1H3,(H,26,27);/q;+1/p-1/t16-,17-,18+,19-,21+;/m0./s1

Molecular Formula

C23H33NaO5

HBD / HBA

2 / 5

Rotierbare Bindungen

10

Schwere Atome

29

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

Treprostinil sodium is the sodium salt form of treprostinil, a synthetic prostacyclin analog used for pulmonary arterial hypertension via continuous subcutaneous or intravenous infusion and inhaled delivery. See treprostinil for complete pharmacological details. This salt formulation is used in sterile injectable preparations for continuous infusion therapy in COPD-associated pulmonary hypertension and PAH.

Yes, Treprostinil Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL561157. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 23663413. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.